<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vi...

Full description

Bibliographic Details
Main Authors: Luigi Principe, Stefano Di Bella, Jacopo Conti, Mariagrazia Perilli, Alessandra Piccirilli, Cristina Mussini, Giuliana Decorti
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/12/1793